Cardiff Oncology Financial Overview
Cardiff Oncology's market cap is currently $162.34M. The company's EPS TTM is $-0.17; its P/E ratio is -3.15; Cardiff Oncology is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
